Plasma Nutrition affirms regulatory standing of ioProtein® and Ingredient Optimized® processing t
The legal validation was based on outside technical analysis and scientific expert opinion.
By: Plasma Nutrition
The validation involved Plasma Nutrition's patent-pending Ingredient Optimized® technology, a processing breakthrough that increases protein bioavailability, as well as ioProtein®, their groundbreaking optimized whey protein isolate. Recent clinical trials on both trained and untrained subjects demonstrated that ioProtein can achieve the same impact as standard WPI using 26% less protein by increasing bioavailability.
To complete the legal process the technology startup worked with Hyman, Phelps & McNamara, P.C., the largest dedicated FDA law firm in the United States. The conclusions were based on scientific expert opinion and a thorough examination of the technical details of ioProtein and the io™ technology.
"Our company has heavily invested in advanced science and technology, and we believe it is important to approach our regulatory affairs in the same way," says Plasma Nutrition's co-founder Chris Flynn-Rozanski. "That's why we worked with one of the leading FDA attorneys in the US to affirm the standing of our technology."
Co-founder Steve Motosko believes that, after this confirmation, Plasma Nutrition will be even better-placed to meet the rising demand of supplement brands for high-quality, sustainably-
About Plasma Nutrition
Plasma Nutrition - https://becomeio.com/